Nanophthalmic patient and normal control eyes with cataract who underwent phacoemulsification with IOLs implantation in ophthalmology training center between 2014 and 2020. Nanophthalmos, Cataract Surgery, small eye
Conditions
Interventions
patient with axial length less than 20 millimeters by IOLs master who underwent cataract surgery,patient with axial length more than 21 millimeters by IOLs master who underwent cataract surgery
Treatment,Treatment
Nanophthalmic patient,normal controlled eyes
Sponsors
None listed
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patient who underwent routine phacoemulsification with IOLs implantation at Mettapracharak (Wat Rhaiking) Hospital during 2014 to 2019. 2. Nanophthalmos in the study was defined as an axial length less than 20 millimeters by IOLs master calculation. 3. Normal control eyes were defined as axial length more than millimeters.
Exclusion criteria
Exclusion criteria: eye with axial length > 25 millimeters, post-operative follow up less than 2 months and eye with structural abnormalities included microcornea which defined by horizontal corneal diameter < 10 millimeters, traumatic cataract, uveitis, retinal and optic nerve abnormalities such as chorioretinal coloboma, retinoschisis and foveal schisis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| final visual acuity and spherical equivalence 2 months after surgery logmar, diopters | — |
Secondary
| Measure | Time frame |
|---|---|
| post operative complication immediate and 2 months after surgery number of event | — |
Countries
Thailand
Contacts
Public ContactSaksakul Engchuan
Yala Hospital
Outcome results
None listed